MARTIN PALMERI
Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology ASHEVILLE, NC NPI 1811005374
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Hematology & Oncology NC BeiGene USA, Inc. All categories
General Payments — all program years on this page
$12,730.61
- Category: General Payments
- Program years: PY2020–2024
- Record count: 164
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $4,151.40 across 49 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,941.41 | 46 |
| Consulting Fee | $1,875.00 | 1 |
| Travel and Lodging | $321.55 | 1 |
| Education | $13.44 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| BeiGene USA, Inc. | $1,894.30 | 2 |
| SERVIER PHARMACEUTICALS LLC | $961.93 | 1 |
| Janssen Biotech, Inc. | $618.78 | 14 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $119.39 | 5 |
| Celgene Corporation | $73.81 | 3 |
| Daiichi Sankyo Inc. | $57.19 | 2 |
| E.R. Squibb & Sons, L.L.C. | $54.99 | 3 |
| EISAI INC. | $48.16 | 2 |
| Incyte Corporation | $40.87 | 2 |
| Myriad Genetic Laboratories, Inc. | $31.05 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $24.45 | 1 |
| ABBVIE INC. | $24.26 | 1 |
| Regeneron Healthcare Solutions, Inc. | $23.03 | 1 |
| Exelixis Inc. | $22.15 | 1 |
| Merck Sharp & Dohme Corporation | $21.27 | 1 |
| Acrotech Biopharma Inc. | $19.09 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $18.88 | 1 |
| Genentech USA, Inc. | $18.77 | 1 |
| ARRAY BIOPHARMA INC | $18.29 | 1 |
| Astellas Pharma US Inc | $17.62 | 1 |
| Adaptive Biotechnologies Corporation | $15.29 | 1 |
| PFIZER INC. | $14.49 | 1 |
| Alexion Pharmaceuticals, Inc. | $13.34 | 1 |
By program year
Records — PY2024 (49)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.